4
Changes in Ownership
Contineum Therapeutics, Inc. Filed Acc 0001437749-24-026903
CMO & Sr VP, Clinical Dev. acquired 12,800 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Huhn Stephen L. · CMO & Sr VP, Clinical Dev.
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-08-13 | Exercise or conversion : show line 1 in the form | +12,800 | $1.01 | $12,928 | 12,800 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-08-13 | Exercise or conversion : show line 2 in the form Stock Option (right to buy) | −12,800 | 161,394 | D |
Loading xslF345X05/rdgdoc.xml…